← Open Payments lookup

RACHEL HIGH: Open Payments

NPI 1386162808 · OAKLAND, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$766 in 25 payments from 17 companies in 2025. Trend: 2023 $34 · 2024 $614 · 2025 $766

Food & beverage: $467Education: $300
CompanyPaymentsAmount
Incyte Corporation4$145
SEAGEN INC.1$100
Gilead Sciences, Inc.1$100
Janssen Biotech, Inc.3$61
Sumitomo Pharma America, Inc.1$58
Novartis Pharmaceuticals Corporation2$45
AstraZeneca Pharmaceuticals LP2$44
Tempus AI, Inc2$39
Eisai Inc.1$28
Merck Sharp & Dohme LLC1$22

Products named: Trodelvy, GEMTESA, JAKAFI, PLUVICTO, XT CDX, Lenvima, TECVAYLI, KEYTRUDA.

Industry payments across MD — which companies pay providers there.